DAWN logo

DAWN
Day One Biopharmaceuticals Inc

1,779
Mkt Cap
$2.22B
Volume
2.99M
52W High
$21.53
52W Low
$5.64
PE Ratio
-20.66
DAWN Fundamentals
Price
$21.53
Prev Close
$21.49
Open
$21.50
50D MA
$19.41
Beta
0.96
Avg. Volume
1.07M
EPS (Annual)
-$1.04
P/B
5.03
Rev/Employee
$888,662.92
$523.56
Loading...
Loading...
News
all
press releases
Day One Biopharmaceuticals, Inc. $DAWN Shares Bought by GC Wealth Management RIA LLC
GC Wealth Management RIA LLC lifted its holdings in shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) by 200.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 150,030 shares of the company's stock after acquir...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Day One Biopharmaceuticals (DAWN) Projected to Post Earnings on Tuesday
Day One Biopharmaceuticals (NASDAQ:DAWN) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat·4d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Day One Biopharmaceuticals to a "hold" rating in a research note on Saturday...
MarketBeat·7d ago
News Placeholder
Servier completes the acquisition of Day One Biopharmaceuticals
Servier completes the acquisition of Day One Biopharmaceuticals Servier completes the acquisition of Day One Biopharmaceuticals PR Newswire SURESNES, France, April 23, 2026 Acquisition...
PR Newswire·9d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 1-Year High - What's Next?
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month High - What's Next...
MarketBeat·12d ago
News Placeholder
150,925 Shares in Day One Biopharmaceuticals, Inc. $DAWN Acquired by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA acquired a new position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Free Report) during the fourth quarter, according to the company in its most recent...
MarketBeat·14d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - Here's What Happened
Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 52-Week High - Time to Buy...
MarketBeat·19d ago
News Placeholder
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Average Rating of "Hold" from Analysts
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN - Get Free Report) have received a consensus rating of "Hold" from the ten ratings firms that are currently covering the company, MarketBeat...
MarketBeat·20d ago
News Placeholder
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 9, 2026 Insiders may stand to...
PR Newswire·23d ago
News Placeholder
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - What's Next?
Day One Biopharmaceuticals (NASDAQ:DAWN) Sets New 1-Year High - What's Next...
MarketBeat·25d ago
<
1
2
...
>

Latest DAWN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.